Barrick Gold Corp. (TSX:ABX, NYSE:GOLD) shares moved higher after the gold producer was upgraded to ‘Buy’ and awarded a $22 price target by analysts at UBS.
The stock added 4.1% at $18.45 on Wednesday afternoon.
Lisata Therapeutics Inc (NASDAQ:LSTA) has announced the first step of an intended multi-part strategic agreement with GATC Health, a leading drug discovery firm leveraging artificial intelligence.
The partnership combines GATC’s proprietary Multiomics Advanced Technology (MAT) AI platform with Lisata’s expertise in drug development to reduce risks and improve efficiency in bringing new therapies to market.
Automaker stocks moved higher on Wednesday afternoon after President Donald Trump’s decision to delay the introduction of some tariffs on the sector.
The US has introduced 25% tariffs on imports from Canada and Mexico but Trump on Wednesday granted automakers a one-month exemption.
atai Life Sciences (NASDAQ:ATAI, ETR:9VC) announced that patient enrollment has been completed in Beckley Psytech’s Phase 2b trial evaluating BPL-003 in treatment-resistant depression (TRD), with topline results expected by mid-2025.
The trial is assessing the efficacy and safety of a single dose of BPL-003, an intranasal formulation of mebufotenin benzoate developed by Beckley Psytech, in which atai is invested, designed for rapid and lasting antidepressant effects with minimal clinic time.
Abercrombie & Fitch (NYSE:ANF) shares fell nearly 14% on Wednesday morning following the company's release of cautious guidance for fiscal year 2025, overshadowing its strong fourth-quarter performance.
The retailer reported a 9% year-over-year increase in fourth-quarter revenue, reaching $1.58 billion, and an 18% rise in net income to $189.7 million.
CrowdStrike Holdings Inc (NASDAQ:CRWD) reported better-than-expected financial results for the fourth quarter but weak profit guidance saw the cybersecurity firm’s shares fall almost 9% on Wednesday.
The company projected earnings for the first quarter between $0.64 and $0.66 per share, significantly below the consensus estimate of $0.95 per share.
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares moved higher after it was disclosed the company insiders have purchased $6 million in shares.
According to filings with the Securities and Exchange Commission (SEC), CEO Stephane Bancel purchased 160,314 shares for $5 million.
Hochschild Mining PLC (LSE:HOC, OTCQX:HCHDF) shares rose 5% in early trading on Wednesday after it announced it had completed the sale of its former Arcata mine and the Azuca project to Sierra Caraz for an undisclosed sum.
The move is part of Hochschild’s strategy to focus on its key assets in Peru - Inmaculada and the Pallancata-Royropata project - as well as its operations in Brazil and Argentina.